Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Parodi

Showing results (151-160 of 256) with videos related to

Pageof 26
Sort By:
Giornale Italiano Di Cardiologia (2006)|February 8, 2014
[Management of antithrombotic therapy in patients undergoing implantation or replacement of cardiac implantable electronic devices]Valerio Zacà, Rossella Marcucci, Guido Parodi, et al.
Cardiovascular Drugs and Therapy|February 17, 2022
Dual Antiplatelet Therapy with 3<sup>rd</sup> Generation P2Y<sub>12</sub> Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose-ResponseFernando Scudiero, Mario E Canonico, Giuseppe D Sanna, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 26, 2015
Management of antithrombotic therapy in patients undergoing electrophysiological device surgeryValerio Zacà, Rossella Marcucci, Guido Parodi, et al.
European Journal of Clinical Investigation|April 8, 2023
Prognostic role of CRP-independent inflammatory patterns in patients undergoing primary percutaneous interventionsFilippo Dossi, Mario Raccis, Guido Parodi, et al.
International Journal of Cardiology|April 1, 2018
Relationship between CHA<sub>2</sub>DS<sub>2</sub>-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndromeFernando Scudiero, Chiara Zocchi, Elena De Vito, et al.
JACC. Cardiovascular Interventions|September 21, 2015
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)Renato Valenti, Rossella Marcucci, Vincenzo Comito, et al.
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 5, 2017
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registryLeonardo De Luca, Fabrizio D'Ascenzo, Giuseppe Musumeci, et al.
Clinical Pharmacokinetics|August 29, 2015
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic StudyDimitrios Alexopoulos, Nikolaos Barampoutis, Vasileios Gkizas, et al.
Pageof 26

Showing results (151-160 of 256) with videos related to

Sort By:
Pageof 26
Giornale Italiano Di Cardiologia (2006)|February 8, 2014
[Management of antithrombotic therapy in patients undergoing implantation or replacement of cardiac implantable electronic devices]Valerio Zacà, Rossella Marcucci, Guido Parodi, et al.
Cardiovascular Drugs and Therapy|February 17, 2022
Dual Antiplatelet Therapy with 3<sup>rd</sup> Generation P2Y<sub>12</sub> Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose-ResponseFernando Scudiero, Mario E Canonico, Giuseppe D Sanna, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 26, 2015
Management of antithrombotic therapy in patients undergoing electrophysiological device surgeryValerio Zacà, Rossella Marcucci, Guido Parodi, et al.
European Journal of Clinical Investigation|April 8, 2023
Prognostic role of CRP-independent inflammatory patterns in patients undergoing primary percutaneous interventionsFilippo Dossi, Mario Raccis, Guido Parodi, et al.
International Journal of Cardiology|April 1, 2018
Relationship between CHA<sub>2</sub>DS<sub>2</sub>-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndromeFernando Scudiero, Chiara Zocchi, Elena De Vito, et al.
JACC. Cardiovascular Interventions|September 21, 2015
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)Renato Valenti, Rossella Marcucci, Vincenzo Comito, et al.
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 5, 2017
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registryLeonardo De Luca, Fabrizio D'Ascenzo, Giuseppe Musumeci, et al.
Clinical Pharmacokinetics|August 29, 2015
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic StudyDimitrios Alexopoulos, Nikolaos Barampoutis, Vasileios Gkizas, et al.
Pageof 26